JW

Joyo Wijaya

Investor

Menlo Park, California

Overview 

Joyo Wijaya, an investor based in Menlo Park, California, has an impressive track record of investing in a diverse range of sectors including Medical Devices, Games, Social Networks, E-commerce, and FinTech. With a Master's degree from Stanford University and extensive experience as an investor in companies like Doorstead, KarmaCheck, and Alto Pharmacy, Joyo has made significant contributions to the startup ecosystem, particularly in the San Francisco Bay Area.

Work Experience 

  • Investor

    2022 - Current

Doorstead uses data and operations technology to provide landlords with upfront guaranteed rent and full property management service.

Raised $37,300,000.00 from M13, Avanta Ventures, MetaProp and Madrona.

  • Investor

    2022

KarmaCheck is a software company that provides a streamlined API platform that offers background screening services for candidate placement.

Raised $64,200,000.00 from GC1 Ventures, AAF Management Ltd., Alumni Ventures, PruVen Capital, Velvet Sea Ventures, Parameter Ventures and NextView Ventures.

  • Investor

    2021

Alto is a digital pharmacy that makes the prescription experience easier.

Raised $680,030,000.00 from What If Ventures, FJ Labs and Anchor Capital GP.

  • Partner

    2019

YouWeb develops products and business models for companies in the consumer internet and mobile computing sectors.

Raised $2,000,000.00 from Praful Shah, Tugboat Ventures, Winston Cho, Peter Relan and Brett Wander.

  • Member

    2014

    See stanfordaande.com

  • Investor

    2015

Discord is an online voice, video, and text communication platform designed for creating communities.

Raised $995,408,718.00 from IPOSharks, Arcane Group and Flat Capital.

  • Investor

    2018

Madorra is a women's health firm that develops solutions to improve quality of life after menopause.

Raised $5,592,809.00 from 51 Labs.

  • Investor

    2015

Zenflow is a medical company that gives new hope to men suffering from BPH symptoms.

Raised $80,068,844.00 from Invus Opportunities, Cook Medical, MedTech Venture Partners and F-Prime Capital.

  • Investor

    2018

Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.

Raised $22,118,936.00 from AbbVie.

Articles About Joyo

Relevant Websites